Technology, Media & Healthcare
How to Underwrite a Diagnostic Laboratory
Underwrite a diagnostic laboratory by analyzing test volume and reimbursement per test by payer, then testing billing compliance and dependence on a few ordering providers or client accounts. Key metrics are revenue per accession, collection rate, test mix, client concentration, and turnaround time. A sudden spike in a single high-reimbursement test should trigger close compliance review.
What makes diagnostic lab services underwriting different
Diagnostic labs process specimens for physicians, hospitals and other clients, billing insurers or clients for each test. Value comes from scale, specialized test menus, efficient automation, CLIA and CAP accreditation, and long-term relationships with ordering physicians and health systems. Risk comes from reimbursement cuts, payer denials, billing compliance issues, client concentration and volatility when testing demand shifts. Some labs have seen revenue surge from a single high-reimbursement test category, then collapse when payers or regulators reacted. Labs also face fraud enforcement related to medical necessity, kickbacks and marketing arrangements.
Lenders underwrite labs on stable collections and diversified clients. They examine payer mix, collections history and compliance, and they discount revenue from test categories with unusual growth or payer scrutiny. Equipment and receivables provide some collateral, but most debt is sized on EBITDA. Equity investors focus on test menu expansion, client acquisition, automation-driven margin improvement and consolidation. They value specialized testing with strong clinical utility and in-network payer contracts, but they underwrite compliance carefully because enforcement can eliminate revenue and lead to large repayments.
Key metrics
Revenue per accession
Reflects test mix and reimbursement, and sudden changes can signal billing issues.
Collection rate by payer
Shows how much billed revenue becomes cash after denials and adjustments.
Test mix
Routine and specialized tests carry different margins and policy risks.
Client or ordering provider concentration
A few clients or physicians may drive most volume.
Turnaround time
Speed and accuracy drive client retention and competitiveness.
Cost per test
Automation and volume reduce costs, while reagent and labor costs can rise.
How to underwrite it, step by step
- Analyze volumes, revenue and collections by test, payer and client.
- Review payer contracts, in-network status and reimbursement rates, including government fee schedules.
- Conduct billing and coding compliance review, including medical necessity documentation.
- Review client and marketing arrangements for compliance with Anti-Kickback and lab-specific laws.
- Confirm CLIA certificates, CAP accreditation and state licenses.
- Assess equipment, automation, reagent contracts and capacity.
- Normalize EBITDA by excluding unsustainable test categories and one-time volumes.
- Stress test for reimbursement cuts, payer audits and client loss.
Due diligence checklist
- Volume, revenue and collections by test, payer and client
- Payer contracts and fee schedules
- CLIA certificates, CAP reports and state licenses
- Billing compliance audits and coding policies
- Client service and marketing agreements
- Payer audit and recoupment correspondence
- Equipment list and reagent rental agreements
- Turnaround time and quality metrics
- Proficiency testing results
- Litigation and government investigation history
Key risks and mitigants
Billing compliance violations
Commission an independent billing audit and require indemnities and escrows for pre-closing liabilities.
Reimbursement cuts
Model fee schedule changes and diversify payer and test mix.
Payer audits and recoupments
Review audit history and reserve for potential repayments.
Client concentration
Size debt excluding the largest client relationships and review contract terms.
Unsustainable test volume
Exclude revenue from unusual test spikes when sizing debt.
Typical financing and deal structure
Diagnostic labs are usually financed with senior term loans or unitranche facilities sized on normalized EBITDA, plus revolvers secured by receivables. Equipment financing and reagent rental agreements fund instruments. Sponsor-backed lab platforms use delayed draw facilities for acquisitions of regional labs or specialty test capabilities. Purchase agreements commonly include specific indemnities and escrows for billing compliance and payer recoupment risk, because R&W insurance generally excludes known issues. Lenders may require periodic compliance reporting and limit leverage for labs with concentrated test categories. Earnouts are sometimes tied to test volumes or payer contract wins.
Red flags
- A sudden surge in a single high-reimbursement test
- Marketing arrangements that compensate based on volume
- Rising payer audits and recoupment requests
- Most revenue from out-of-network claims
- Client concentration with one health system or physician group
Frequently asked questions
How are diagnostic labs valued?
Labs are valued on EBITDA multiples adjusted for test mix, payer mix, growth, compliance and client concentration. Labs with diversified clients, specialized tests and in-network contracts typically command higher multiples. Underwriters normalize EBITDA to exclude unsustainable test volumes and potential compliance liabilities before applying a multiple.
What compliance risks do clinical labs face?
Labs face risks around medical necessity, billing and coding, marketing arrangements, client discounts and lab-specific anti-kickback rules. Payers may audit and seek repayments, and government enforcement can bring penalties. Diligence includes billing audits and legal review of client and marketing relationships before any acquisition or financing closes.
What is revenue per accession?
Revenue per accession is the average collected revenue for each specimen or order processed by the lab. It reflects test mix and reimbursement rates. Tracking it over time helps identify shifts in mix or billing practices, and unusual increases can signal compliance concerns that warrant further review by the underwriter.
Can a lab get an asset-based loan?
Labs can borrow against receivables through asset-based revolvers, with advance rates based on collection history and payer mix. Government receivables may require special arrangements. Most term debt is sized on EBITDA because equipment and receivables alone usually cannot support the full financing a buyer needs.
Related terms
Underwrite a diagnostic lab services deal in minutes
Drop a deck or data room. Underridge returns a verdict, investment memo, term sheet and a live model, with every headline figure traced to a page, a formula or a labeled assumption. Ten underwrites free.
Try Underridge freeEducational content, not investment, credit, legal or tax advice. Benchmarks are common practitioner rules of thumb and vary by lender, market and cycle.